Fundraising Fox
🦊/Companies
Sign in

EviCure

1 known investors

Find your way into EviCure

EviCure is a pre-clinical biopharmaceutical company developing extracellular vesicle-based therapies for cancer treatment using AI and disease modeling. The company uses AI-powered platforms to identify EV subpopulations with therapeutic potential and enables targeted drug delivery for oncology applications.

AI & Machine LearningBiotechHealthtechMedical Devices

Founders & leadership

EJEric J. Messika
Eric J. MessikainCEO
AB
Aharon BrodieCTO
CB
Chaya BrodieConsultant

Investors · 1

Peregrine VenturesOr Yehuda · $500K – $3M

Frequently asked questions

What does EviCure do?
EviCure is a pre-clinical biopharmaceutical company developing extracellular vesicle-based therapies for cancer treatment using AI and disease modeling. The company uses AI-powered platforms to identify EV subpopulations with therapeutic potential and enables targeted drug delivery for oncology applications.
Who are EviCure's investors?
EviCure's investors include Peregrine Ventures.